Archives of Epilepsy

Scope & Guideline

Illuminating the path to understanding epilepsy.

Introduction

Welcome to the Archives of Epilepsy information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Archives of Epilepsy, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageMulti-Language
ISSN-
PublisherGALENOS PUBL HOUSE
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationARCH EPILEPSY / Archiv. Epilepsy
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKacamak Sokak 21/1, ISTANBUL, Findikzade 34093, TURKIYE

Aims and Scopes

The Archives of Epilepsy focuses on advancing the understanding of epilepsy through a variety of research methodologies, including clinical studies, experimental research, and systematic reviews. The journal aims to publish high-quality research that contributes to the diagnosis, treatment, and management of epilepsy and related disorders.
  1. Clinical Research on Epilepsy Management:
    The journal emphasizes clinical studies that investigate various aspects of epilepsy management, including medication adherence, treatment outcomes, and the impact of epilepsy on quality of life.
  2. Neurobiological and Genetic Studies:
    Research exploring the neurobiological mechanisms and genetic factors contributing to epilepsy is a core focus, including studies on specific gene variants and their associated phenotypes.
  3. Epidemiological and Public Health Aspects:
    The journal addresses the epidemiology of epilepsy, examining trends, risk factors, and public health implications, particularly in the context of global health crises such as the COVID-19 pandemic.
  4. Innovative Therapeutic Approaches:
    Archives of Epilepsy publishes research on novel therapeutic strategies, including pharmacological trials, surgical interventions, and alternative treatments such as the ketogenic diet.
  5. Neuropsychological and Cognitive Impact:
    The impact of epilepsy and its treatments on cognitive functions and neuropsychological outcomes is a significant area of interest, with studies assessing the cognitive effects of antiepileptic drugs.
The journal has adapted to emerging trends in epilepsy research, reflecting new challenges and innovations in the field. Recent publications indicate a shift towards more integrative and interdisciplinary approaches to epilepsy research.
  1. Impact of COVID-19 on Epilepsy:
    Research examining the effects of the COVID-19 pandemic on epilepsy patients, including changes in treatment patterns and seizure frequency, has emerged as a significant theme, highlighting the need for adaptive management during crises.
  2. Health Equity and Access to Care:
    Studies addressing health equity in epilepsy care, including disparities in treatment access and outcomes for different demographics, have gained traction, reflecting a broader societal focus on equity in healthcare.
  3. Neuropsychological Assessments and Quality of Life:
    There is an increasing emphasis on understanding the neuropsychological aspects of epilepsy and their impact on patients' quality of life, leading to studies that explore cognitive functions and psychosocial dimensions.
  4. Innovative Diagnostic and Monitoring Techniques:
    Emerging themes include the use of advanced diagnostic techniques and monitoring technologies, such as video-EEG and digital neuropsychological assessments, which enhance the understanding and management of epilepsy.
  5. Genetic and Precision Medicine Approaches:
    The exploration of genetic factors and precision medicine in epilepsy treatment is on the rise, with research focusing on how individual genetic profiles can inform tailored treatment strategies.

Declining or Waning

While the journal has seen a growth in certain areas of research, there are themes that appear to be declining in prominence. This shift may reflect changing research priorities or advances in understanding that render earlier topics less critical.
  1. Traditional Pharmacological Studies:
    There has been a noticeable decrease in studies that solely focus on traditional pharmacological treatments without exploring their broader implications or novel combinations with other therapies.
  2. Basic Science Studies Without Clinical Relevance:
    Research that emphasizes basic science without direct clinical application or relevance to patient care has become less common, as there is a stronger push towards translational research that connects laboratory findings to clinical practice.
  3. Single-Center Observational Studies:
    The trend towards multi-center and larger-scale observational studies has led to a decline in single-center studies, which may not provide sufficient generalizability or impact in the field.

Similar Journals

Neurology and Therapy

Pioneering Discoveries in Neurology for a Healthier Future
Publisher: SPRINGER LONDON LTDISSN: 2193-8253Frequency: 2 issues/year

Neurology and Therapy, published by SPRINGER LONDON LTD, stands as a pivotal platform for researchers and practitioners in the field of neurology and its therapeutic applications. This Open Access journal, active since 2012, facilitates the dissemination of innovative studies and cutting-edge findings aimed at improving neurological health. With an impressive ranking in the 2023 Scopus Rankings, where it holds a Q2 category in Neurology and a Q1 category in Clinical Neurology, it underscores its prominence in advancing neurological research. The journal's intriguing scope encompasses a wide-ranging exploration of neurological disorders, treatment methodologies, and healthcare strategies, making it a valuable resource for those vested in enhancing patient outcomes. With an appealing average impact factor, readers are encouraged to dive into the latest advancements and engage with the scholarly discussions that are shaping the future of neurology.

Journal of Pediatric Neuropsychology

Empowering professionals to enhance children's neuropsychological outcomes.
Publisher: SPRINGERNATUREISSN: 2199-2681Frequency: 4 issues/year

Journal of Pediatric Neuropsychology is a pioneering academic journal dedicated to advancing the field of pediatric neuropsychology. Published by SpringerNature, this journal serves as a vital platform for researchers, clinicians, and students aiming to explore the complexities of neuropsychological development in children. With ISSN 2199-2681 and E-ISSN 2199-2673, the journal focuses on a broad spectrum of topics including cognitive processes, neurological disorders, and the impact of neuropsychology on educational and therapeutic practices. Though currently not listed as an Open Access journal, it aims to disseminate knowledge that influences clinical practices and supports interdisciplinary collaboration. The Journal of Pediatric Neuropsychology stands out for its commitment to enhancing understanding within this specialized field, making it an essential resource for professionals and researchers dedicated to improving outcomes for children with neuropsychological challenges.

EPILEPSY & BEHAVIOR

Pioneering research at the nexus of neurology and behavior.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 1525-5050Frequency: 12 issues/year

EPILEPSY & BEHAVIOR is a premier journal dedicated to advancing the field of neurology and behavioral neuroscience, published by Academic Press Inc. Elsevier Science. With a focus on the complex interplay between epilepsy and behavioral disorders, this journal serves as a pivotal platform for researchers, clinicians, and educators alike. The journal holds a commendable position with a Q2 ranking in key categories such as Behavioral Neuroscience and Clinical Neurology, highlighting its influence and contributions to the scientific community. Notably, EPILEPSY & BEHAVIOR is indexed in Scopus, ranking in the top percentiles across various related fields, which underscores the quality and relevance of the research it publishes. As it navigates from its inception in 2000 to its ongoing work into 2024, the journal remains committed to disseminating high-quality research and insights that address critical issues in epilepsy and associated behavioral challenges, providing invaluable resources for ongoing education and innovation in the field.

NEUROPEDIATRICS

Fostering breakthroughs in the understanding of pediatric neurology.
Publisher: GEORG THIEME VERLAG KGISSN: 0174-304XFrequency: 6 issues/year

NEUROPEDIATRICS is a prominent academic journal published by GEORG THIEME VERLAG KG, dedicated to advancing the understanding and treatment of neurological disorders in children. Established in 1980, this journal has consistently provided a platform for innovative research and clinical practice in the fields of pediatrics and neurology, culminating in its recognition across various rankings; it holds a Q2 rating in Pediatrics, Perinatology and Child Health, and Q3 in both Medicine (miscellaneous) and Neurology (clinical) as of 2023. While NEUROPEDIATRICS is not an open access journal, it remains a crucial resource for researchers, clinicians, and students who seek cutting-edge insights and evidence-based practices in the management of pediatric neurological issues. As a result, NEUROPEDIATRICS plays an indispensable role in shaping future research directions and improving health outcomes in this vital field.

BRAIN & DEVELOPMENT

Transforming Research into Clinical Insights
Publisher: ELSEVIERISSN: 0387-7604Frequency: 10 issues/year

BRAIN & DEVELOPMENT is a prestigious academic journal published by ELSEVIER, renowned for its pivotal contributions to the fields of developmental neuroscience, neurology, and pediatrics. Established in 1979, this journal has become an essential resource for researchers and clinicians alike, as it explores the complexities of brain development and associated neurological disorders in children. With an impactful focus on advancing scientific understanding, BRAIN & DEVELOPMENT is currently ranked in the Q3 quartile in Developmental Neuroscience and Clinical Neurology and Q2 in Pediatrics, reflecting its significance within the medical community. Its ISSN 0387-7604 and E-ISSN 1872-7131 underline its established presence in academic literature. While the journal does not offer open access options, it continues to be a key platform for disseminating new research findings and fostering innovation in the understanding of pediatric neurological health. The journal's commitment to quality research is further evidenced by its ongoing publication trajectory up until 2024, making it a vital source of knowledge for students, professionals, and educators in related fields.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Exploring the complexities of child neurological health.
Publisher: ELSEVIER SCI LTDISSN: 1090-3798Frequency: 6 issues/year

European Journal of Paediatric Neurology, published by Elsevier Science Ltd, is a premier academic journal dedicated to advancing the field of paediatric neurology. With its ISSN 1090-3798 and E-ISSN 1532-2130, this journal serves as a vital resource for researchers, clinicians, and students alike, focusing on the latest findings and innovative treatments in paediatric neurological disorders. The journal has established itself as a leading publication in its field, achieving a Q1 classification in Pediatrics, Perinatology and Child Health, and holding a reputable Q2 status in Clinical Neurology as of 2023. Positioned within the top 88th percentile in Pediatrics and the 76th percentile in Clinical Neurology according to Scopus ranks, it publishes rigorous peer-reviewed articles that contribute significantly to clinical practice and research. Although not open access, the journal provides vital insights into the complexities of neurological conditions affecting the pediatric population, making it an essential tool for scholars and professionals striving to improve child health outcomes. With a publication trajectory spanning from 1997 to 2024, it continues to be at the forefront of paediatric neurological research, inspiring innovation and collaboration in the scientific community.

Clinical Epileptology

Elevating the standard of care through rigorous research.
Publisher: SPRINGER HEIDELBERGISSN: 2948-104XFrequency: 4 issues/year

Clinical Epileptology, published by Springer Heidelberg, is an emerging open-access journal that aims to advance the understanding of epilepsy through rigorous research and clinical studies. With an ISSN of 2948-104X and E-ISSN of 2948-1058, this journal serves as a vital platform for researchers, clinicians, and students within the fields of Neurology, Pediatrics, and Perinatology. Although still in its formative years, spanning from 2023 to 2024, the journal aspires to fill the knowledge gaps in epilepsy research, thereby improving patient outcomes. Despite its initial Scopus rankings placing it within the 12th and 19th percentiles in respective categories, Clinical Epileptology is poised to make a significant impact by fostering interdisciplinary collaboration and disseminating high-quality findings. With options for open access, this journal ensures that groundbreaking research is readily available to a global audience, encouraging the ongoing dialogue that is crucial to advancing the field. Intended for a diverse readership, including academic researchers, healthcare professionals, and students, Clinical Epileptology is committed to becoming a cornerstone of epilepsy research.

NEUROLOGY

Exploring breakthroughs in neurological research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0028-3878Frequency: 48 issues/year

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Advancing epilepsy research for a brighter future.
Publisher: W B SAUNDERS CO LTDISSN: 1059-1311Frequency: 10 issues/year

SEIZURE - EUROPEAN JOURNAL OF EPILEPSY is a leading journal published by W B SAUNDERS CO LTD, specializing in the field of epilepsy and seizure disorders. Since its inception in 1992, this journal has committed itself to advancing research and understanding in neurology, achieving a respectable 2023 impact factor reflected by its Q2 rankings in Medicine (miscellaneous), Neurology, and Clinical Neurology categories. With an impressive Scopus ranking that places it in the top 35% of journals in Neuroscience and Neurology, SEIZURE is dedicated to promoting high-quality research and clinical studies that offer insights into epilepsy management and treatment. Although not an open-access journal, it maintains a diverse array of original articles, reviews, and case studies catering to academicians, medical professionals, and students looking to expand their knowledge on epilepsy. This journal is pivotal for those seeking to stay abreast of the latest trends, therapies, and findings in the neuroclinical landscape.

EPILEPSIA

Connecting researchers to revolutionize epilepsy care.
Publisher: WILEYISSN: 0013-9580Frequency: 12 issues/year

EPILEPSIA is a premier academic journal published by Wiley, with a storied history dating back to 1909, making it a cornerstone in the field of epilepsy research and neurology. With an impressive impact factor reflecting its robust contribution to the academic community, EPILEPSIA is categorized in the top quartile (Q1) in both neurology and clinical neurology as of 2023, underscoring its significance and prestige. The journal is ranked #15 out of 192 in Neuroscience & Neurology and #34 out of 400 in Medicine & Neurology (clinical) within Scopus, indicating its essential role in advancing knowledge and treatments related to epilepsy. Researchers and clinicians are encouraged to contribute groundbreaking studies, case reports, and reviews that inform best practices and improve patient outcomes. Although EPILEPSIA currently does not offer open access options, its detailed exploration of both fundamental and clinical aspects of epilepsy ensures wide dissemination of crucial findings among professionals and students alike, furthering the understanding and management of this complex condition.